FFCP PHASE1:Mm9::chr19:31985250..31985262,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=34|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr19:31985250..31985262,+|id=chr19:31985250..31985262,+|ontology_enrichment_celltype=CL:0000624!1.09e-14!8;CL:0000893!4.43e-13!6;CL:0002489!4.43e-13!6;CL:0000898!4.43e-13!6;CL:0000809!4.43e-13!6;CL:0000810!4.43e-13!6;CL:0000895!4.43e-13!6;CL:0000808!4.43e-13!6;CL:0000894!4.43e-13!6;CL:0000806!4.43e-13!6;CL:0000807!4.43e-13!6;CL:0000805!4.43e-13!6;CL:0002425!4.43e-13!6;CL:0002436!4.43e-13!6;CL:0002427!4.43e-13!6;CL:0002428!4.43e-13!6;CL:0002429!4.43e-13!6;CL:0002433!4.43e-13!6;CL:0002431!4.43e-13!6;CL:0002432!4.43e-13!6;CL:0000791!4.82e-13!9;CL:0000789!4.82e-13!9;CL:0002420!4.82e-13!9;CL:0002419!4.82e-13!9;CL:0000790!4.82e-13!9;CL:0000084!1.20e-10!11;CL:0000827!1.20e-10!11;CL:0000838!9.56e-10!12;CL:0000542!5.54e-09!13;CL:0000051!5.54e-09!13;CL:0000988!1.48e-08!32;CL:0002032!1.48e-08!32;CL:0000037!1.48e-08!32;CL:0000566!1.48e-08!32;CL:0000837!1.48e-08!32;CL:0000738!7.99e-07!17;CL:0002087!7.99e-07!17|ontology_enrichment_celltype_v019_2=CL:0000893,1.33e-10,6;CL:0002489,1.33e-10,6;CL:0000898,1.33e-10,6;CL:0000809,1.33e-10,6;CL:0000810,1.33e-10,6;CL:0000895,1.33e-10,6;CL:0000808,1.33e-10,6;CL:0000894,1.33e-10,6;CL:0000806,1.33e-10,6;CL:0000807,1.33e-10,6;CL:0000805,1.33e-10,6;CL:0002425,1.33e-10,6;CL:0002436,1.33e-10,6;CL:0002427,1.33e-10,6;CL:0002428,1.33e-10,6;CL:0002429,1.33e-10,6;CL:0002433,1.33e-10,6;CL:0002431,1.33e-10,6;CL:0002432,1.33e-10,6;CL:0000624,3.41e-08,8;CL:0000791,2.19e-07,9;CL:0000789,2.19e-07,9;CL:0002420,2.19e-07,9;CL:0002419,2.19e-07,9;CL:0000790,2.19e-07,9|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0004177!2.87e-09!29;UBERON:0002370!7.48e-07!23;UBERON:0000974!7.48e-07!23;UBERON:0004807!7.48e-07!23;UBERON:0005058!7.48e-07!23;UBERON:0003351!7.48e-07!23;UBERON:0009113!7.48e-07!23;UBERON:0003295!7.48e-07!23;UBERON:0009722!7.48e-07!23;UBERON:0005562!7.48e-07!23;UBERON:0007690!7.48e-07!23|ontology_enrichment_uberon_v019_2=|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0.140788722151667,0.70219357896598,3.93801326918661,1.67521533890206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.59445373517761,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0.130120442962704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0.228778173206523,7.81900777971734,4.89830083132803,3.45499934511059,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr19:31985250..31985262,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=34 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr19:31985250..31985262,+ | |||
|description=CAGE_peak_at_chr19:31985250..31985262,+ | |||
|id=chr19:31985250..31985262,+ | |||
|ontology_enrichment_celltype=CL:0000624!1.09e-14!8;CL:0000893!4.43e-13!6;CL:0002489!4.43e-13!6;CL:0000898!4.43e-13!6;CL:0000809!4.43e-13!6;CL:0000810!4.43e-13!6;CL:0000895!4.43e-13!6;CL:0000808!4.43e-13!6;CL:0000894!4.43e-13!6;CL:0000806!4.43e-13!6;CL:0000807!4.43e-13!6;CL:0000805!4.43e-13!6;CL:0002425!4.43e-13!6;CL:0002436!4.43e-13!6;CL:0002427!4.43e-13!6;CL:0002428!4.43e-13!6;CL:0002429!4.43e-13!6;CL:0002433!4.43e-13!6;CL:0002431!4.43e-13!6;CL:0002432!4.43e-13!6;CL:0000791!4.82e-13!9;CL:0000789!4.82e-13!9;CL:0002420!4.82e-13!9;CL:0002419!4.82e-13!9;CL:0000790!4.82e-13!9;CL:0000084!1.20e-10!11;CL:0000827!1.20e-10!11;CL:0000838!9.56e-10!12;CL:0000542!5.54e-09!13;CL:0000051!5.54e-09!13;CL:0000988!1.48e-08!32;CL:0002032!1.48e-08!32;CL:0000037!1.48e-08!32;CL:0000566!1.48e-08!32;CL:0000837!1.48e-08!32;CL:0000738!7.99e-07!17;CL:0002087!7.99e-07!17 | |||
|ontology_enrichment_celltype_v019_2=CL:0000893,1.33e-10,6;CL:0002489,1.33e-10,6;CL:0000898,1.33e-10,6;CL:0000809,1.33e-10,6;CL:0000810,1.33e-10,6;CL:0000895,1.33e-10,6;CL:0000808,1.33e-10,6;CL:0000894,1.33e-10,6;CL:0000806,1.33e-10,6;CL:0000807,1.33e-10,6;CL:0000805,1.33e-10,6;CL:0002425,1.33e-10,6;CL:0002436,1.33e-10,6;CL:0002427,1.33e-10,6;CL:0002428,1.33e-10,6;CL:0002429,1.33e-10,6;CL:0002433,1.33e-10,6;CL:0002431,1.33e-10,6;CL:0002432,1.33e-10,6;CL:0000624,3.41e-08,8;CL:0000791,2.19e-07,9;CL:0000789,2.19e-07,9;CL:0002420,2.19e-07,9;CL:0002419,2.19e-07,9;CL:0000790,2.19e-07,9 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0004177!2.87e-09!29;UBERON:0002370!7.48e-07!23;UBERON:0000974!7.48e-07!23;UBERON:0004807!7.48e-07!23;UBERON:0005058!7.48e-07!23;UBERON:0003351!7.48e-07!23;UBERON:0009113!7.48e-07!23;UBERON:0003295!7.48e-07!23;UBERON:0009722!7.48e-07!23;UBERON:0005562!7.48e-07!23;UBERON:0007690!7.48e-07!23 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0.129123323441576,0.140788722151667,0.70219357896598,3.93801326918661,1.67521533890206,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.59445373517761,0.599902730993408,0.254140454146129,0,0,0,0,0,0,0,0,0,0,0,0.130120442962704,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.274561413188081,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.170870880797853,0,0,0,0,0.228778173206523,7.81900777971734,4.89830083132803,3.45499934511059,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0974578807397524,0,0.116876902181569,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.243106717068294,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.147198920134397,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr19:31985250..31985262,+ | |||
}} |
Latest revision as of 21:43, 3 August 2015
Short description: | p@chr19:31985250..31985262, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr19:31985250..31985262, + |
Coexpression cluster: | MCL_coexpression_mm9:34 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
thymocyte | 1.33e-10 | 6 |
double negative thymocyte | 1.33e-10 | 6 |
naive T cell | 1.33e-10 | 6 |
double-positive, alpha-beta thymocyte | 1.33e-10 | 6 |
CD4-positive, alpha-beta thymocyte | 1.33e-10 | 6 |
naive thymus-derived CD4-positive, alpha-beta T cell | 1.33e-10 | 6 |
DN4 thymocyte | 1.33e-10 | 6 |
DN1 thymic pro-T cell | 1.33e-10 | 6 |
DN2 thymocyte | 1.33e-10 | 6 |
DN3 thymocyte | 1.33e-10 | 6 |
immature single positive thymocyte | 1.33e-10 | 6 |
early T lineage precursor | 1.33e-10 | 6 |
mature CD4 single-positive thymocyte | 1.33e-10 | 6 |
resting double-positive thymocyte | 1.33e-10 | 6 |
double-positive blast | 1.33e-10 | 6 |
CD69-positive double-positive thymocyte | 1.33e-10 | 6 |
CD69-positive, CD4-positive single-positive thymocyte | 1.33e-10 | 6 |
CD4-positive, CD8-intermediate double-positive thymocyte | 1.33e-10 | 6 |
CD24-positive, CD4 single-positive thymocyte | 1.33e-10 | 6 |
CD4-positive, alpha-beta T cell | 3.41e-08 | 8 |
mature alpha-beta T cell | 2.19e-07 | 9 |
alpha-beta T cell | 2.19e-07 | 9 |
immature T cell | 2.19e-07 | 9 |
mature T cell | 2.19e-07 | 9 |
immature alpha-beta T cell | 2.19e-07 | 9 |